Disclosures for "Dual Amyloid Beta/Tau Vaccine PRX123 Surrogate Results in Robust Clearance of Amyloid Plaques in Brains of Aggressive APP/PS1 Mouse Model"
-
Ms. Barbour has received personal compensation for serving as an employee of Prothena Biosciences. Ms. Barbour has stock in Prothena Biosciences. Ms. Barbour has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Tourino has nothing to disclose.
-
Miss Trumble has nothing to disclose.
-
Ms. Louie has nothing to disclose.
-
Dr. Kinney has received personal compensation for serving as an employee of Prothena. Dr. Kinney has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Prothena. Dr. Kinney has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Libra Therapeutics. Dr. Kinney has stock in Prothena. Dr. Kinney has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Zago has received personal compensation for serving as an employee of Prothena . Dr. Zago has received stock or an ownership interest from Prothena.
-
Dr. Campbell has received personal compensation for serving as an employee of Prothena Biosciences. Dr. Campbell has received personal compensation in the range of $0-$499 for serving as a Consultant for MindImmune Therapeutics. Dr. Campbell has stock in Prothena Biosciences. Dr. Campbell has stock in MindImmune Therapeutics.